ALK vs LSTR

ALK's deterministic health signals are weak, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score, raising concerns about financial health transparency. Despite strong revenue growth of 22.6% and a low forward P/E of 6.00 suggesting potential recovery, the company faces severe profitability and earnings headwinds, with ROE at 3.53%, negative YoY earnings growth (-66.3%), and a very low profit margin of 1.06%. Insider selling, a bearish technical trend, and a current price ($50.87) significantly above the Graham Number ($31.48) further suggest overvaluation and lack of confidence from insiders. While analysts maintain a 'strong_buy' recommendation with a $70.87 target, the fundamental and cash flow weaknesses outweigh near-term optimism.

LSTR exhibits a severe valuation disconnect, trading at $168.27 despite a Graham Number of $41.71 and an Intrinsic Value of $23.17. While the Piotroski F-Score of 4/9 indicates stable financial health and the low Debt/Equity ratio (0.17) provides a safety buffer, these are overshadowed by crashing fundamentals. With YoY earnings growth at -46.50% and revenue declining, the current P/E of 50.84 is unsustainable. The bearish technical trend (10/100) and analyst target price ($152.27) further suggest significant downside risk.